查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827369

血库市场按产品类型、应用、最终用户、测试类型、采集方法和捐赠者类型划分－2025-2032 年全球预测

Blood Banking Market by Product Type, Application, End User, Testing Type, Collection Method, Donor Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血库市场将成长 463.1 亿美元，复合年增长率为 13.43%。

主要市场统计数据
基准年2024年 168.9亿美元
预计2025年 191.5亿美元
预测年份：2032年 463.1亿美元
复合年增长率（%） 13.43%

探索现代血库格局，其中临床需求、捐赠者多样性、检测进步和运作弹性融合，重新定义病患照护服务

血库产业正处于临床需求、技术加速发展和供应链现状变化的关键交汇点。捐赠者筛检、自动化采血和分子检测的进步正在改变血液成分的采购、处理和与接受者配对的方式，而人口和流行病学压力正在重塑需求模式。临床相关人员和实践领导者越来越关注整个采血网路的弹性、检测的可靠性，以及在不中断临床服务的情况下整合新的安全模式的能力。

从门诊手术中心到大型医院系统，在临床环境中，越来越需要在保持充足库存的同时最大限度地降低输血风险。这项驱动力正在刺激病原体灭活技术、自动化单采系统和增强型传染病检查平台的投资。同时，捐赠者群体也呈现多样化，家庭替代捐献者、有偿捐献者和自愿捐献者在招募、留存和合规性方面各自体现着不同的运作考量。捐赠者类型和采集方法（全血采集 vs. 单采）之间的相互作用决定了处理工作流程和下游检测的优先顺序。

在未来几年，那些将临床实践与强大的捐赠者参与、可靠的检测通讯协定和灵活的供应策略相结合的组织将最有能力提供安全的输血服务。本引言透过将临床优先事项与营运槓桿联繫起来，为后续分析奠定了基础，为深入探讨随之而来的技术、监管和地缘政治变化奠定了基础。

技术进步、临床实践变化、监管加强以及供应链弹性如何重塑整个血库系统的营运重点

在技​​术创新、临床实践发展以及供应链韧性需求的推动下，血库格局正在经历转型变革。新型病原体灭活系统和先进的核酸检测技术正在提升安全基准，使血液服务更有效地降低输血传播感染的风险。同时，血液分离和全血处理的自动化正在简化流程，减少人工操作的差异，并支持更高品质的成分製备。伴随这项技术变革的是，越来越多的数位互动平台被用于招募和留住自愿捐血者，从而改善捐血体验，同时优化采血计画和库存预测。

临床变化同样重要。患者血液管理计划和精准输血策略最大限度地减少不必要的输血，并优先匹配特定成分类型，例如血小板、红血球、血浆和冷沉淀，以满足个别患者的需求。因此，诊断检测和快速血型分析以支持个人化输血决策正变得越来越重要。与这些临床趋势同步，法律规范也不断发展，强调加强感染疾病监测和更严格的检测方法验证。这些监管变化推动了对经过验证的检测技术和品管系统的投资。

在营运方面，该产业正在汲取过去供应中断的教训，透过多元化供应商关係、投资低温运输物流以及探索本地生产和加工方案。在对能够提供高吞吐量、安全性和可追溯性的整合解决方案的需求推动下，血库、医院/诊所和诊断设备製造商之间的跨部门合作正变得越来越普遍。总而言之，这些转变正在重新调整血液服务机构在资本配置、员工发展和策略性伙伴关係关係方面的优先顺序，以满足临床医生和患者日益增长的期望。

评估关税波动和贸易政策动态如何增加采购复杂性并推动血库营运的策略供应链调整

关税调整和贸易政策格局对血库设备、耗材和诊断剂的采购模式产生了重大影响。关键製造投入和成品医疗设备的进口关税上调，可能会增加用于检测、加工和收集的设备和耗材的到岸成本。这些发展趋势促使采购团队重新评估其供应商组合，尽可能优先考虑本地或区域生产，并寻求合约保护以吸收短期成本波动。对于临床项目而言，实际结果是，成本可预测性是选择检测平台或扩大血液分离能力的关键考虑因素。

除了直接影响价格外，关税相关的不确定性还会延长前置作业时间，并使库存规划更加复杂。製造商和经销商可能会调整其分销策略以对冲关税波动，迫使血库和医院建立更强大的库存缓衝，或寻找可行的替代设备和试剂供应商。因此，采购和临床工程部门必须更紧密地合作，评估供应商之间的等效性，并在不影响临床性能或法规合规性的前提检验替代产品。

此外，关税可能成为近岸外包和区域供应链发展的催化剂，促使供应商在更靠近终端市场的地方建立製造和组装业务。虽然此类转变可以增强长期韧性，但需要资本投入和时间，因此企业应优先进行情境规划，与供应商进行主动谈判，并将总拥有成本分析纳入采购决策。最终，关税变动的累积影响凸显了策略采购管治、跨职能应变计画和敏捷营运对于维持安全输血服务连续性的重要性。

详细的細項分析揭示了产品类型、测试方法、收集方法、捐赠者类别、应用程式和最终用户设定如何需要差异化的营运和临床策略

对细分市场的细緻理解对于协调临床路径、采购选择和营运模式至关重要。依产品类型进行分析可以揭示冷沉淀、血浆、血小板、红血球和全血等成分在物流和临床需求方面的差异，每种成分都需要特定的采集、储存和检测工作流程，从而影响保质期和配送策略。诊断、研究和输血用例中应用主导的差异决定了所需检测的深度，并影响了可追溯性和文件记录方面的优先级，尤其是在研究应用可能需要额外样本和资料处理的情况下。

门诊手术中心、血库、医院和诊所各自在容量、人员配备和设施限制方面都存在差异。区分检测类型（血型检测和传染病检查）有助于明确技术选择和品管方法。考虑采集方法（单采血与全血采集）有助于明确在捐赠者时间负担、成分产量和下游处理复杂性方面的权衡，从而影响捐赠者参与策略和容量规划。

按捐赠者类型细分进一步增加了实践设计的复杂性。家庭替代捐赠者、付费捐赠者和自愿捐赠者各自体现出独特的伦理、监管和物流方面的问题，这些方面会影响招募工作和社区推广。综合考虑这些细分因素，服务提供者和供应商能够根据不同客户和患者群体的特定临床和营运需求，调整其产品系列、检测演算法和服务交付模式。

美洲、欧洲、中东和非洲以及亚太地区的差异如何影响营运重点、监管回应和供应恢復策略

区域动态在塑造血库工作的重点和能力方面发挥关键作用。在美洲，成熟的血库网路和一体化的医院系统创造了整合、采用先进检测手段和集中库存管理的良好环境。该地区高度重视临床标准化和捐赠者招募宣传活动，支持持续改善血库成分的使用实践和品质系统。

在欧洲、中东和非洲，卫生系统的成熟度各不相同，因此营运模式也各有不同。该地区的高所得市场强调严格的监管合规、分子检测的采用以及对病原体灭活方法的投资，而资源匮乏的地区则优先考虑可扩展的采集策略、低温运输物流和能力建设。官民合作关係和区域倡议通常可作为传播最佳实践和标准化培训的机制，从而加强紧急应变和稀缺捐助者管理的跨国合作。

亚太地区的人口结构变化和快速的医疗保健现代化进程加速了对强大的采集和检测基础设施的需求。该地区对自动化血液分离系统和照护现场血型检测技术的投资正在增加，同时也引入了集中式和分散式采集模式。该地区的政策制定者和医疗保健提供者也在探索本地製造机会，以减少对国际供应链的依赖，增强对贸易相关中断的抵御能力，并改善关键耗材的取得。

检验製造商、诊断公司和服务供应商如何投资自动化、伙伴关係和安全创新，以重新调整其竞争定位和临床价值

关键产业参与者，包括设备供应商、诊断製造商、检测实验室和血浆分馏，是创新、策略伙伴关係和产能扩张的核心。领先的製造商持续投资于自动化和仪器互通性，以减少手动任务并提高可追溯性，而诊断公司则正在加速开发多重检测和快速血型分型解决方案，以加快临床决策速度。设备製造商和实验室之间的合作也在不断扩大，这有助于提供包含硬体、试剂和验证支援的一体化服务。

随着企业寻求扩大临床产品组合併确保下游销售管道，策略伙伴关係和定向收购正在塑造竞争格​​局。为了满足日益增长的安全预期，一些公司优先投资病原体减少技术并扩展试剂库。同时，专注于血液采集技术的供应商正在改进血液分离系统的人体工学和吞吐量，以改善捐血者的体验并提高每次采血的产量，使医院和血库等最终用户能够更轻鬆地采用新方法，同时保持符合监管标准。

为临床领导、采购团队和技术合作伙伴提供切实可行的建议，以提高血库系统的安全性、供应弹性和营运效率

临床服务、采购和製造领导者应优先考虑一系列协作行动，将新洞察转化为营运韧性和临床品质。首先，建立多元化的供应商关係，并为关键耗材和设备寻找合格的替代供应商，以降低单一供应商风险并缓解关税带来的成本波动。此外，应结合包含价格调整条款和库存寄售模式的合约策略，以平衡成本控制和可用性。

投资诊断和处理技术，以提高安全性和通量。采用先进的传染病检查平台和病原体灭活系统可以降低临床风险并简化法规遵从性，而采集和成分处理的自动化可以减少差异性和劳动强度。在进行技术投资的同时，透过数位平台来简化自愿捐赠者的预约和保留流程，从而增强捐赠者的参与度，并在适用的情况下，根据家庭替代和付费捐赠者群体的特点，实施推广定制的推广计划。

在营运方面，我们将制定一套跨职能的紧急时应对计画，整合临床工程、供应链和物流领导团队，确保在发生中断时快速检验替代产品并实现无缝衔接。我们将透过数据驱动的补货触发机制和基于场景的库存策略，加强低温运输物流和库存管治。最后，我们将投资于员工发展和能力建设项目，以确保临床和实验室负责人能够有效操作新平台并维护高品质的文檔，以满足不断变化的监管要求。

结合相关人员访谈、技术检验和与二手资讯最后覆核的多方法研究方法将产生可靠且可操作的发现。

本分析基于结构化研究方法，将与该领域相关人员的初步定性接触与严格的次要证据基准相结合。初步研究包括对血库营运负责人、临床实验室主任、采购主管和医疗技术供应商进行半结构化访谈，以了解他们对技术采用、捐赠策略和供应链限制的第一手观点。这些见解与第二手资料（包括监管指南、血液采集和检测平台的技术规范、同行评审的输血安全临床文献以及公开的公司资讯披露）进行了整合，以检验趋势并协调不同的叙述。

数据整合优先考虑临床、营运和供应链领域主题的融合。在可能的情况下，技术规格和监管要求与製造商文件和已发布的标准进行交叉引用，以确保准确性。在整个研究过程中，我们关注最终使用者和区域差异，并认识到异质医疗环境的固有限制。研究结果由具有临床实验室和输血医学经验的专家进行审查，以检验其实际适用性，并揭示其在实际实践中实施的细微影响。

总结相关性、技术采用和跨职能协作是维持临床安全和营运连续性的支柱

现代血库环境既带来挑战，也带来机会，需要采取协调一致的策略应对措施。检测和处理技术的进步扩展了临床医生和操作人员可用的套件，而捐赠者的多样性和区域差异性则要求采取灵活、因地制宜的方法。贸易政策变化和供应链中断进一步加剧了营运的复杂性，必须透过多元化采购和主动的紧急时应对计画来积极应对。

将临床品质要求与严格的采购管治相结合，投资于可提高安全性和吞吐量的技术，并在整个供应链中建立牢固伙伴关係关係的组织，将能够更好地维持医疗服务的连续性。未来的道路强调韧性、数据主导的决策以及将临床目标与实际采购和营运能力相结合的适应性策略。透过专注于这些优先事项，相关人员可以维护安全的输血服务，并更有效地应对新出现的风险和机会。

目录

第一章：前言

第二章 研究方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 扩大病原体减少技术以提高血液安全性和保质期
  • 实施区块链解决方案，确保血液供应链的安全可追溯性和法规遵循
  • 建立分散式微型血液中心，改善农村社区的血液获取服务
  • 用于快速血型鑑定和感染筛检的可携式和就地检验设备的进展
  • 细胞疗法投资的增加推动了对专用血液成分处理设备的需求
  • 血库和远端医疗平台之间的合作正在不断加强，以招募和留住虚拟捐赠者。
  • 机器学习模型的出现可以预测捐赠者延期风险并优化招募策略
  • 整合3D生物列印技术，实现人工血液和血浆替代品的大规模生产

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：血库市场（依产品类型）

  • 冷沉淀
  • 电浆
  • 血小板
  • 红血球
  • 全血

第九章血库市场的应用

  • 诊断
  • 研究
  • 输血

第 10 章。血库市场（依最终用户划分）

  • 门诊手术中心
  • 血库
  • 医院和诊所

第 11 章 血库市场（依测试类型）

  • 血型检测
  • 传染病检查

第 12 章：以采集方式分類的血库市场

  • 血液成分采集
  • 全血采集

第十三章血库市场（依捐赠者类型）

  • 家庭替代捐赠者
  • 付费捐赠者
  • 自愿捐献者

第十四章血库市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章血库市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章：各国血库市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Haemonetics Corporation
    • Grifols, SA
    • Terumo Corporation
    • Fresenius Kabi AG
    • Macopharma SA
    • Bio-Rad Laboratories, Inc.
    • QuidelOrtho Corporation
    • Immucor, Inc.
    • Cerus Corporation
    • Hologic, Inc.
Product Code: MRR-434CCDA04D00

The Blood Banking Market is projected to grow by USD 46.31 billion at a CAGR of 13.43% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.89 billion
Estimated Year [2025] USD 19.15 billion
Forecast Year [2032] USD 46.31 billion
CAGR (%) 13.43%

Introducing the contemporary blood banking landscape where clinical demands, donor diversity, testing advances, and operational resilience converge to redefine patient care delivery

The blood banking field stands at a pivotal confluence of clinical necessity, technological acceleration, and shifting supply chain realities. Advances in donor screening, automated collection, and molecular testing have altered how blood components are sourced, processed, and matched to recipients, while demographic and epidemiological pressures are reshaping demand patterns. Clinical stakeholders and operations leaders are increasingly focused on resilience across collection networks, testing reliability, and the ability to integrate new safety modalities without disrupting clinical delivery.

Across clinical settings, from ambulatory surgical centers to large hospital systems, the imperative to minimize transfusion risks while maintaining adequate inventories has intensified. This dynamic has stimulated investment in pathogen reduction technologies, automated apheresis systems, and enhanced infectious disease testing platforms. At the same time, the donor landscape is diversifying: family replacement donors, paid donors, and voluntary donors present different operational considerations for recruitment, retention, and regulatory compliance. The interplay between donor type and collection method-whether whole blood collection or apheresis collection-shapes processing workflows and downstream testing priorities.

In the coming years, organizations that align clinical practice with robust donor engagement, reliable testing protocols, and adaptive supply strategies will be best positioned to deliver safe transfusion services. This introduction frames the ensuing analysis by connecting clinical priorities with operational levers, setting the context for deeper consideration of technological, regulatory, and geopolitical shifts that follow.

How technological advancement, clinical practice changes, regulatory tightening, and supply chain resilience are collectively reshaping operational priorities across blood banking systems

The blood banking landscape is undergoing transformative shifts driven by technological innovation, clinical practice evolution, and the imperative of supply chain resilience. Novel pathogen reduction systems and advanced nucleic acid testing have raised the safety baseline, enabling blood services to mitigate transfusion-transmitted risks more effectively. Simultaneously, automation in apheresis and whole blood processing streamlines throughput, reduces manual variability, and supports higher-quality component preparation. These technological shifts are complemented by the increasing adoption of digital engagement platforms to recruit and retain voluntary donors, improving donor experience while optimizing collection scheduling and inventory forecasting.

Clinical change is equally significant. Patient blood management programs and precision transfusion strategies prioritize minimizing unnecessary transfusions and matching specific component types-such as platelets, red blood cells, plasma, and cryoprecipitate-to individual patient needs. As a result, diagnostic testing and rapid blood grouping are taking on heightened importance to support tailored transfusion decisions. Alongside these clinical trends, regulatory frameworks continue to evolve, emphasizing enhanced surveillance for infectious agents and stricter validation of testing methodologies. This regulatory tightening incentivizes investments in validated testing technologies and quality management systems.

Operationally, the sector is responding to the lessons of prior supply disruptions by diversifying supplier relationships, investing in cold-chain logistics, and exploring local manufacturing and processing options. Cross-sector collaborations between blood banks, hospitals and clinics, and diagnostic manufacturers are becoming more common, driven by the need for integrated solutions that deliver on throughput, safety, and traceability. Taken together, these shifts are recalibrating how blood services prioritize capital allocation, workforce development, and strategic partnerships to meet rising expectations from clinicians and patients alike.

Evaluating how tariff shifts and trade policy dynamics are intensifying procurement complexity and prompting strategic supply chain adaptation across blood banking operations

Tariff adjustments and trade policy developments have a material influence on the procurement landscape for blood banking equipment, consumables, and diagnostic reagents. Increases in import duties on key manufacturing inputs and finished medical devices can raise landed costs for instrumentation and disposables used in testing, processing, and collection. This dynamic prompts procurement teams to reassess supplier portfolios, prioritize local or regional manufacturing where feasible, and seek contractual protections that absorb short-term cost fluctuations. For clinical programs, the practical consequence is a heightened focus on cost predictability when selecting testing platforms or scaling up apheresis capabilities.

Beyond direct price effects, tariff-related uncertainty can elongate lead times and complicate inventory planning. Manufacturers and distributors may adjust distribution strategies to hedge against tariff volatility, which in turn requires blood banks and hospitals to build more robust inventory buffers or to qualify alternate validated devices and reagent sources. Procurement and clinical engineering functions therefore must collaborate more closely to evaluate equivalency across suppliers and to validate alternate products without compromising clinical performance or regulatory compliance.

Furthermore, tariffs can act as a catalyst for nearshoring and regional supply chain development, incentivizing suppliers to establish manufacturing or assembly operations closer to end markets. While such shifts can enhance long-term resilience, they also require capital investment and time, so organizations should prioritize scenario planning, engage in proactive supplier negotiations, and incorporate total-cost-of-ownership analyses into purchasing decisions. Ultimately, the cumulative effects of tariff dynamics underscore the importance of strategic procurement governance, cross-functional contingency planning, and agile operations to maintain continuity of safe transfusion services.

Deep segmentation analysis reveals how product types, testing modalities, collection methods, donor categories, applications, and end-user settings demand differentiated operational and clinical strategies

A nuanced understanding of segmentation is essential for tailoring clinical pathways, procurement choices, and operational models. When analyzed by product type, differences emerge between the logistical and clinical requirements for components such as cryoprecipitate, plasma, platelets, red blood cells, and whole blood, each demanding specific collection, storage, and testing workflows that affect shelf life and distribution strategies. Application-driven differentiation-spanning diagnostics, research, and transfusion use cases-shapes the depth of testing required and influences priorities around traceability and documentation, especially where research applications may require additional sample processing and data handling.

End-user contexts also prescribe operational distinctions: ambulatory surgical centers, blood banks, and hospitals and clinics each operate under different throughput, staffing, and facility constraints, meaning that solutions must be calibrated to fit institutional scale and clinical intensity. Testing type segmentation, separating blood grouping testing from infectious disease testing, clarifies technology selection and quality control approaches because these testing categories carry distinct regulatory pathways and validation requirements. Collection method considerations-comparing apheresis collection with whole blood collection-highlight trade-offs in donor time commitment, component yield, and downstream processing complexity, which have implications for donor engagement strategies and capacity planning.

Donor type segmentation further complicates operational design. Family replacement donors, paid donors, and voluntary donors each present unique ethical, regulatory, and logistical dimensions that impact recruitment practices and community outreach. Taken together, these segmentation lenses enable providers and suppliers to align product portfolios, testing algorithms, and service delivery models with the specific clinical and operational needs of diverse customers and patient populations.

How regional variations across the Americas, Europe Middle East & Africa, and Asia-Pacific produce distinct operational priorities, regulatory responses, and supply resilience strategies

Regional dynamics play a pivotal role in shaping blood banking priorities and capabilities. In the Americas, established networks of blood banks and integrated hospital systems create an environment where consolidation, advanced testing adoption, and centralized inventory management are prevalent. This region's focus on clinical standardization and donor recruitment campaigns supports continued refinement of component utilization practices and quality systems.

Across Europe, Middle East & Africa, heterogeneity in health system maturity drives diverse operational models. High-income markets within the region emphasize rigorous regulatory compliance, molecular testing adoption, and investment in pathogen reduction methodologies, while lower-resource settings prioritize scalable collection strategies, cold-chain logistics, and capacity building. Public-private partnerships and regional initiatives often serve as mechanisms to spread best practices and standardize training, enhancing cross-border collaboration in emergency responses and rare-donor management.

In Asia-Pacific, population dynamics and rapid healthcare modernization are accelerating demand for robust collection and testing infrastructure. The region exhibits a mix of centralized and distributed collection models, with increasing investment in automated apheresis systems and point-of-care blood grouping technologies. Policymakers and providers in this region are also exploring regional manufacturing opportunities to reduce dependence on long international supply lines, thereby strengthening resilience against trade-related disruptions and improving access to critical consumables.

Examining how manufacturers, diagnostics firms, and service providers are investing in automation, partnerships, and safety innovations to realign competitive positioning and clinical value

Key industry participants have become focal points for innovation, strategic partnerships, and capacity expansion, with activity spanning equipment suppliers, diagnostic manufacturers, testing laboratories, and plasma fractionators. Leading manufacturers continue to invest in automation and device interoperability to reduce manual touches and improve traceability, while diagnostic firms are accelerating development of multiplexed assays and rapid blood grouping solutions that enable faster clinical decision making. Collaborative arrangements between equipment makers and testing laboratories are also growing, facilitating integrated service offerings that bundle hardware, reagents, and validation support.

Strategic partnerships and targeted acquisitions are shaping the competitive landscape as companies seek to broaden their clinical portfolios or secure downstream distribution channels. Some organizations are prioritizing investments in pathogen reduction technologies and expanded reagent libraries to meet heightened safety expectations. Meanwhile, suppliers focused on collection technologies are advancing apheresis system ergonomics and throughput, improving donor experience and supporting higher yield per collection event. Across the sector, there is a clear emphasis on building solutions that address both clinical efficacy and operational efficiency, enabling end users such as hospitals and blood banks to more readily adopt new modalities while maintaining compliance with regulatory standards.

Actionable recommendations for clinical leaders, procurement teams, and technology partners to fortify safety, supply resilience, and operational efficiency within blood banking systems

Leaders in clinical services, procurement, and manufacturing should prioritize a set of coordinated actions that translate emerging insights into operational resilience and clinical quality. First, diversify supplier relationships and qualify alternate validated vendors for critical consumables and instruments to reduce single-source exposure and mitigate tariff-driven cost volatility. Complement this with contractual strategies that include price adjustment clauses and inventory consignment models to balance cost management with availability.

Invest in diagnostic and processing technologies that strengthen the safety envelope while improving throughput. Adoption of advanced infectious disease testing platforms and pathogen reduction systems can reduce clinical risk and streamline regulatory compliance, while automation in collection and component processing can cut variability and labor intensity. Parallel to technology investments, enhance donor engagement through digital platforms that simplify scheduling and retention for voluntary donors, and tailor outreach programs to the characteristics of family replacement and paid donor pools when applicable.

Operationally, develop cross-functional contingency plans that integrate clinical engineering, supply chain, and clinical leadership to ensure rapid validation of alternate products and seamless substitution during disruptions. Strengthen cold-chain logistics and inventory governance using data-driven replenishment triggers and scenario-based stock policies. Finally, invest in workforce training and competency programs to ensure clinical staff and laboratory personnel can operate new platforms effectively and maintain quality documentation to meet evolving regulatory expectations.

Description of the multi-method research approach combining stakeholder interviews, technical validation, and cross-checked secondary sources to ensure robust and actionable findings

This analysis is grounded in a structured research approach combining primary qualitative engagement with sector stakeholders and a rigorous secondary evidence baseline. Primary research involved semi-structured interviews with operational leaders in blood banks, clinical laboratory directors, procurement executives, and medical technology suppliers to capture firsthand perspectives on technology adoption, donor strategies, and supply chain constraints. These insights were triangulated with secondary materials, including regulatory guidance, technical specifications for collection and testing platforms, peer-reviewed clinical literature on transfusion safety, and publicly available company disclosures to validate trends and reconcile differing narratives.

Data synthesis prioritized thematic convergence across clinical, operational, and supply chain domains. Where possible, technical specifications and regulatory requirements were cross-checked against manufacturer documentation and published standards to ensure accuracy. Throughout the research process, attention was given to contextual differences across end users and regions, acknowledging the limitations inherent to heterogeneous healthcare settings. Findings were reviewed by subject-matter experts with clinical laboratory and transfusion medicine experience to validate practical applicability and to surface nuanced implications for implementation in real-world operations.

Concluding synthesis that emphasizes resilience, technological adoption, and cross-functional coordination as the pillars for sustained clinical safety and operational continuity

The contemporary blood banking environment presents both challenges and opportunities that require calibrated, strategic responses. Technological advancements in testing and processing are expanding the toolkit available to clinicians and operators, while donor diversity and regional variability demand flexible and context-sensitive approaches. Trade policy changes and supply chain disruptions add a layer of operational complexity that must be actively managed through diversified sourcing and proactive contingency planning.

Organizations that integrate clinical quality imperatives with disciplined procurement governance, invest in technologies that enhance safety and throughput, and cultivate strong partnerships across the supply chain will be better positioned to maintain continuity of care. The path forward emphasizes resilience, data-driven decision making, and adaptive strategies that align clinical objectives with the realities of sourcing and operational capacity. By focusing on these priorities, stakeholders can sustain safe transfusion services and respond more effectively to emergent risks and opportunities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of pathogen reduction technologies to enhance blood safety and shelf life
  • 5.2. Adoption of blockchain solutions for secure traceability and regulatory compliance in blood supply chains
  • 5.3. Implementation of decentralized micro blood centers to increase accessibility in rural communities
  • 5.4. Advances in portable and point-of-care testing devices for rapid blood group and infectious screening
  • 5.5. Rising investment in cellular therapies driving demand for specialized blood component processing equipment
  • 5.6. Growing collaboration between blood banks and telehealth platforms for virtual donor recruitment and retention
  • 5.7. Emergence of machine learning models to predict donor deferral risk and optimize recruitment strategies
  • 5.8. Integration of 3D bioprinting techniques for scalable production of artificial blood and plasma substitutes

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Banking Market, by Product Type

  • 8.1. Cryoprecipitate
  • 8.2. Plasma
  • 8.3. Platelets
  • 8.4. Red Blood Cells
  • 8.5. Whole Blood

9. Blood Banking Market, by Application

  • 9.1. Diagnostics
  • 9.2. Research
  • 9.3. Transfusion

10. Blood Banking Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Blood Banks
  • 10.3. Hospitals And Clinics

11. Blood Banking Market, by Testing Type

  • 11.1. Blood Grouping Testing
  • 11.2. Infectious Disease Testing

12. Blood Banking Market, by Collection Method

  • 12.1. Apheresis Collection
  • 12.2. Whole Blood Collection

13. Blood Banking Market, by Donor Type

  • 13.1. Family Replacement Donor
  • 13.2. Paid Donor
  • 13.3. Voluntary Donor

14. Blood Banking Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Blood Banking Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Banking Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Haemonetics Corporation
    • 17.3.2. Grifols, S.A.
    • 17.3.3. Terumo Corporation
    • 17.3.4. Fresenius Kabi AG
    • 17.3.5. Macopharma SA
    • 17.3.6. Bio-Rad Laboratories, Inc.
    • 17.3.7. QuidelOrtho Corporation
    • 17.3.8. Immucor, Inc.
    • 17.3.9. Cerus Corporation
    • 17.3.10. Hologic, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. GCC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. GCC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. GCC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. GCC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. GCC BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. GCC BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GCC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. GCC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. GCC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 266. GCC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 267. GCC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. GCC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. G7 BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. G7 BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. G7 BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. G7 BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. G7 BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. G7 BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. G7 BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. G7 BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. G7 BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. G7 BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. G7 BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 308. G7 BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 309. G7 BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. G7 BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. NATO BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. NATO BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. NATO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. NATO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. NATO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. NATO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. NATO BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. NATO BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. NATO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. NATO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. NATO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 322. NATO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 323. NATO BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. NATO BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. UNITED STATES BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED STATES BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. UNITED STATES BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED STATES BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED STATES BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED STATES BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. UNITED STATES BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED STATES BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 337. UNITED STATES BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED STATES BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. CANADA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. CANADA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. CANADA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. CANADA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 345. CANADA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. CANADA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. CANADA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 348. CANADA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 349. CANADA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 350. CANADA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 351. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 352. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 353. MEXICO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 354. MEXICO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 355. MEXICO BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 356. MEXICO BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 357. MEXICO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 358. MEXICO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 359. MEXICO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)

TABLE 360